One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...

In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

XCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud ...

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

For the first time, clumps of human cells called organoids were fully integrated with the brains of rats—and influenced their ...

Improvements in public health have allowed humankind to survive to older ages than ever before, but, for many people, these ...